Literature DB >> 11956100

Cell division is required for de novo methylation of CpG islands in bladder cancer cells.

Mihaela Velicescu1, Daniel J Weisenberger, Felicidad A Gonzales, Yvonne C Tsai, Carvell T Nguyen, Peter A Jones.   

Abstract

Cell division is essential for tumor development and progression. Methylation-mediated silencing caused by aberrant de novo methylation of CpG islands located in the promoter regions of growth regulatory genes occurs frequently in human cancers. We investigated the relationship between cell division and de novo methylation to determine whether de novo methylation can occur in the absence of cell division in cancer cells. We treated T24 bladder carcinoma cells with 5-Aza-2'-deoxycytidine to induce a transient demethylation and then compared the timing and kinetics of remethylation of the p16 gene locus under conditions of either G(0)-G(1) growth arrest induced by serum starvation and confluence or continuous cell proliferation in complete medium. Variable levels of remethylation were detected in CpG poor regions of DNA, as well as repetitive DNA elements in the absence of cell division, yet no remethylation occurred at CpG islands under these conditions. This correlated with continuous expression of p16 protein in these cells. DNA methyltransferase (DNMT)1 and DNMT3b3 proteins were undetectable in 5-Aza-2'-deoxycytidine-treated and untreated nondividing cells, and their mRNA transcripts were down-regulated in these cells. Although DNMT3a mRNA levels were also reduced, they recovered to original levels in nondividing cells after drug treatment. Our results suggest that cell division is required for de novo methylation of CpG islands and that DNMT3a may play a role in methylating CpG poor regions or repetitive DNA elements outside of the S phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956100

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Novel protein kinase induced during sporangial cleavage in the oomycete Phytophthora infestans.

Authors:  Howard S Judelson; Samuel Roberts
Journal:  Eukaryot Cell       Date:  2002-10

2.  Hypermethylation in bladder cancer: biological pathways and translational applications.

Authors:  Marta Sánchez-Carbayo
Journal:  Tumour Biol       Date:  2012-01-25

Review 3.  Applying whole-genome studies of epigenetic regulation to study human disease.

Authors:  J D Lieb; S Beck; M L Bulyk; P Farnham; N Hattori; S Henikoff; X S Liu; K Okumura; K Shiota; T Ushijima; J M Greally
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

4.  Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer.

Authors:  Eveline J Steine; Mathias Ehrich; George W Bell; Arjun Raj; Seshamma Reddy; Alexander van Oudenaarden; Rudolf Jaenisch; Heinz G Linhart
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

5.  The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression.

Authors:  Mazin Al-Salihi; Margaret Yu; David M Burnett; Amanda Alexander; Wolfram E Samlowski; Frank A Fitzpatrick
Journal:  Epigenetics       Date:  2011-08-01       Impact factor: 4.528

6.  Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia.

Authors:  Young S Kim; Guoren Deng
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

Review 7.  Stem cell chronicles: autobiographies within genomes.

Authors:  Darryl Shibata; Simon Tavaré
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

8.  Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Yoshihito Nakagawa; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Hiroshi Nakano; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Clin Exp Med       Date:  2009-01-30       Impact factor: 3.984

9.  Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

10.  Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas.

Authors:  Seung-Jin Hong; Young-Ho Kim; Young-Deok Choi; Ki-Ouk Min; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.